Research Papers

Have a look in our latest publications

In the past years, several projects have been carried out including the assessment of technologies for different clinical conditions and the evaluation of pharmacist services around the world. As results, we have published scientific articles in different international journals.

  • Discontinuation of non-anti-TNF drugs for rheumatoid arthritis in interventional versus observational studies: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018 Jul 18.

  • Medical Treatments for Acromegaly: A Systematic Review and Network Meta-Analysis. Value Health. 2018 Jul;21(7):874-880. 

  • Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis. CNS Drugs. 2018 Jul 16.

  • Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections. Mycoses. 2018 Jun 12.

  • Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS). BioDrugs. 2018 Jun 5.

  • An innovative and comprehensive technique to evaluate different measures of medication adherence: The network meta-analysis. Res Social Adm Pharm. 2018 May 19.

  • Sustained Virological Response in Special Populations with Chronic Hepatitis C Using Interferon-Free Treatments: A Systematic Review and Meta-analysis of Observational Cohort Studies. Clin Drug Investig. 2018 May;38(5):389-400.

  • Letter to the Editor: “Limited Health Literacy in Portugal Assessed with the Newest Vital Sign” by Dagmara Paiva and Colleagues. Acta Med Port. 2017;30(12):861-869. Acta Med Port. 2018 Mar 29;31(3):182-183.

  • Impact of discharge medication counseling in the cardiology unit of a tertiary hospital in Brazil: A randomized controlled trial. Clinics (Sao Paulo). 2018;73.

  • Mapping the characteristics of network meta-analyses on drug therapy: A systematic review. PLoS One. 2018 Apr 30;13(4).

  • Pharmacist-led discharge medication counselling: A scoping review. J Eval Clin Pract. 2018 Jun;24(3):570-579.

  • A case study of polypharmacy management in nine European countries: Implications for change management and implementation. PLoS One. 2018 Apr 18;13(4).

  • Cross-cultural adaptation and validation of a European Portuguese version of the 8-item Morisky medication adherence scale. Rev Port Cardiol. 2018 Apr;37(4).

  • Scholarly publishing depends on peer reviewers. Pharm Pract (Granada). 2018 Jan-Mar;16(1).

  • Response to the letter entitled: Developing an adherence in hypertension questionnaire short version, MUAH-16: Statistical and methodological issues. J Clin Hypertens (Greenwich). 2018 Apr;20(4).

  • Direct costs of type 2 diabetes: a brazilian cost-of-illness study. Int J Technol Assess Health Care. 2018 Jan;34(2).

  • Antioxidant effects of vitamins in type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetol Metab Syndr. 2018 Mar 14;10:18.

  • Characterization of pharmacists’ interventions in asthma management: A systematic review. J Am Pharm Assoc (2003). 2018 Mar – Apr;58(2).

  • Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis. Eur Child Adolesc Psychiatry. 2018.

  • Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018 Jan 21;8(1).

  • Impact on process results of clinical decision support systems (CDSSs) applied to medication use: overview of systematic reviews. Pharm Pract (Granada). 2017 Oct-Dec;15(4).

  • [Factor XIII-guided treatment algorithm reduces blood transfusion in burn surgery]. Rev Bras Anestesiol. 2018 May – Jun;68(3).

  • Developing an adherence in hypertension questionnaire short version: MUAH-16. J Clin Hypertens (Greenwich). 2018 Jan;20(1).

  • A modified Delphi study to determine the level of consensus across the European Union on the structures, processes and desired outcomes of the management of polypharmacy in older people. PLoS One. 2017 Nov 20;12(11).

  • Qualitative meta-synthesis of barriers and facilitators that influence the implementation of community pharmacy services: perspectives of patients, nurses and general medical practitioners. BMJ Open. 2017 Sep 5;7(9).

  • Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study.  Regul Toxicol Pharmacol. 2017 Nov;90:87-94.

  • Redefining the pharmacology and pharmacy subject category in the journal citation reports using medical subject headings (MeSH). Int J Clin Pharm. 2017 Oct;39(5):989-997.

  • Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis. J Pharm Pharmacol. 2017 Dec;69(12):1672-1683.

  • A network meta-analysis of primary prophylaxis for invasive fungal infection in haematological patients. J Clin Pharm Ther. 2017 Oct;42(5):530-538.

  • New pharmacy-specific Medical Subject Headings included in the 2017 database. Am J Health Syst Pharm. 2017 Aug 1;74(15):1128-1129.

  • Influence of the mode of administration on the results of medication adherence questionnaires. J Eval Clin Pract. 2017 Dec;23(6):1252-1257.

  • Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients. Clinics (Sao Paulo). 2017 May;72(5):317-324.

  • Fluconazole Doses Used for Prophylaxis of Invasive Fungal Infection in Neonatal Intensive Care Units: A Network Meta-Analysis. J Pediatr. 2017 Jun;185:129-135.

  • Use of Intervention Mapping to Enhance Health Care Professional Practice: A Systematic Review. Health Educ Behav. 2017 Aug;44(4):524-535.

  • The complexity of implementation factors in professional pharmacy services. Res Social Adm Pharm. 2018 May;14(5):498-500.

  • Diethylpropion and mazindol: An end to the discussion? Rev Assoc Med Bras (1992). 2017 Mar;63(3):203-206.

  • Safety of Treatments for ADHD in Adults: Pairwise and Network Meta-Analyses. J Atten Disord. 2017 Mar 1.

  • Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study. Ther Clin Risk Manag. 2017 Jan 10;13:59-64.

  • Analysis of ten years of publishing in Pharmacy Practice. Pharm Pract (Granada). 2016 Oct-Dec;14(4):847.

  • Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy. Core Evid. 2016 Dec 14;11:49-61.

  • Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis. Mycoses. 2017 Mar;60(3):146-154.

  • Current perceptions of the term Clinical Pharmacy and its relationship to Pharmaceutical Care: a survey of members of the European Society of Clinical Pharmacy. Int J Clin Pharm. 2016 Dec;38(6):1445-1456.

  • Bradford’s law, the long tail principle, and transparency in Journal Impact Factor calculations. Pharm Pract (Granada). 2016 Jul-Sep;14(3):842.

  • Network meta-analysis of first- and second-generation protease inhibitors for chronic hepatitis C genotype 1: efficacy based on RVR and SVR 24. Eur J Clin Pharmacol. 2017 Jan;73(1):1-14.

  • A Comparison of Patient-Centered Care in Pharmacy Curricula in the United States and Europe. Am J Pharm Educ. 2016 Jun 25;80(5):83.

  • Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics. Pharmacogenomics J. 2017 Dec;17(6):488-493.

  • A Systematic Review of Evidence-Based Community Pharmacy Services Aimed at the Prevention of Cardiovascular Disease. J Manag Care Spec Pharm. 2016 Jun;22(6):699-713.

  • Best practice strategies to safeguard drug prescribing and drug administration: an anthology of expert views and opinions. Int J Clin Pharm. 2016 Apr;38(2):362-73.

  • Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Res Social Adm Pharm. 2017 Jan – Feb;13(1):201-208